Healthcare of Ontario Pension Plan Trust Fund Reduces Stock Position in Exponent, Inc. $EXPO

Healthcare of Ontario Pension Plan Trust Fund cut its holdings in Exponent, Inc. (NASDAQ:EXPO) by 59.3% during the first quarter, Holdings Channel reports. The institutional investor owned 21,215 shares of the business services provider’s stock after selling 30,900 shares during the period. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Exponent were worth $1,384,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of EXPO. Bell Investment Advisors Inc boosted its position in shares of Exponent by 423.6% during the 1st quarter. Bell Investment Advisors Inc now owns 377 shares of the business services provider’s stock worth $25,000 after acquiring an additional 305 shares in the last quarter. Allworth Financial LP increased its holdings in shares of Exponent by 86.1% in the 4th quarter. Allworth Financial LP now owns 469 shares of the business services provider’s stock valued at $33,000 after acquiring an additional 217 shares during the last quarter. Bessemer Group Inc. raised its position in shares of Exponent by 37.1% during the 1st quarter. Bessemer Group Inc. now owns 717 shares of the business services provider’s stock worth $47,000 after acquiring an additional 194 shares in the last quarter. UMB Bank n.a. lifted its stake in Exponent by 54.8% during the fourth quarter. UMB Bank n.a. now owns 904 shares of the business services provider’s stock worth $63,000 after purchasing an additional 320 shares during the last quarter. Finally, Hantz Financial Services Inc. lifted its stake in Exponent by 129.0% during the fourth quarter. Hantz Financial Services Inc. now owns 907 shares of the business services provider’s stock worth $63,000 after purchasing an additional 511 shares during the last quarter. 92.37% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Exponent

In other news, VP Bradley A. James sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $57.47, for a total transaction of $114,940.00. Following the transaction, the vice president directly owned 1,105 shares in the company, valued at approximately $63,504.35. This trade represents a 64.41% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Catherine Corrigan sold 4,194 shares of the firm’s stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $54.06, for a total transaction of $226,727.64. Following the transaction, the chief executive officer owned 105,218 shares in the company, valued at approximately $5,688,085.08. This trade represents a 3.83% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 15,324 shares of company stock worth $855,019. 1.60% of the stock is currently owned by corporate insiders.

Exponent Stock Performance

Shares of EXPO stock opened at $66.85 on Friday. The stock’s 50-day moving average is $60.00 and its two-hundred day moving average is $65.23. Exponent, Inc. has a 1 year low of $51.91 and a 1 year high of $81.95. The firm has a market cap of $3.24 billion, a price-to-earnings ratio of 29.98 and a beta of 0.72.

Exponent (NASDAQ:EXPO) last posted its earnings results on Thursday, July 30th. The business services provider reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.55 by $0.05. The business had revenue of $171.61 million during the quarter, compared to the consensus estimate of $144.99 million. Exponent had a return on equity of 29.63% and a net margin of 17.67%.The business’s quarterly revenue was up 12.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.52 EPS. As a group, research analysts predict that Exponent, Inc. will post 2.3 EPS for the current year.

Exponent Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, September 18th. Shareholders of record on Friday, September 4th will be given a dividend of $0.31 per share. The ex-dividend date of this dividend is Friday, September 4th. This represents a $1.24 annualized dividend and a yield of 1.9%. Exponent’s payout ratio is 55.61%.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on EXPO shares. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Exponent in a report on Friday, July 17th. JPMorgan Chase & Co. raised their price objective on shares of Exponent from $80.00 to $90.00 and gave the stock an “overweight” rating in a report on Friday. Finally, UBS Group set a $72.00 price objective on shares of Exponent and gave the stock a “neutral” rating in a research report on Friday. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $81.00.

More Exponent News

Here are the key news stories impacting Exponent this week:

• Positive Sentiment: Q2 earnings and revenue exceeded expectations: Exponent reported adjusted earnings of $0.60 per share versus the $0.55 consensus estimate. Revenue reached approximately $171.6 million, while operating profit rose 63.1% year over year to $28.0 million. Exponent Q2 earnings report
• Positive Sentiment: Growth outlook raised: Management increased its 2026 net revenue growth forecast to 9%–10%, citing expanding demand for services related to artificial intelligence. The improved guidance reinforces expectations for continued business momentum. Exponent raises 2026 growth outlook
• Positive Sentiment: JPMorgan raised its price target: JPMorgan Chase increased its target from $80 to $90 and assigned an “overweight” rating, implying substantial potential appreciation from the referenced $66.94 price. JPMorgan raises Exponent price target
• Positive Sentiment: Capital returns increased: The board declared a quarterly dividend of $0.31 per share and expanded the company’s stock-repurchase authorization by $50 million. Exponent dividend and repurchase announcement
• Neutral Sentiment: The dividend offers an annualized yield of roughly 1.9%, with payment scheduled for September 18 to shareholders of record on September 4.
• Negative Sentiment: Insider-trading data showed 17 reported insider sales and no purchases over the past six months, which may raise a modest sentiment concern. Quarterly operating cash flow was also negative at $1.0 million, although capital spending remained limited at $2.5 million.

About Exponent

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.